[ad_1]

For the previous couple of years, varied readers have inquired about Mane Biotech (now niostem) and its hair loss App and machine. The firm CEO Dr. Carlos Chacón shared a number of updates with me in 2021, however instructed me that they had been nonetheless in stealth mode. This is now not true, and he e-mailed me some fascinating new particulars a few days in the past.

Niostem Device
Niostem Device (previously Mane Biotech).

Niostem: New Name for Mane Biotech

Of most significance, Mane Biotech has been rebranded to niostem. On the brand new firm’s web site, it says that they’re headquartered in Germany and the hair loss machine can be launched in 2023. Note that niostem’s co-founders are Dr. Chacón and an individual named Emil Aliev.

The earlier than and after images on niostem’s web site present important hair progress after 6 months of machine use. One of the explanations that this product is popping out so quick is as a result of no medical trials appear to have been required. I’m happy about this, as a result of most firms that endure three phases of medical trials take eternally (e.g., Follica) or usually quit because of lack of funding.

Note there there’s one online anecdotal report on the German hair loss discussion board from somebody who took half in a Mane Biotech examine. Not certain if dependable.

Dr. Chacón beforehand labored on the prestigious Max Planck Institute for Biology for Ageing in Germany. Some of his previous analysis on hair follicle stem cells could be found here and on his Linkedin.

He is likely one of the co-applicants in a patent filed by the Max Planck Institute in 2016. It entails the culturing of epidermis-derived stem cells, together with hair follicles. Among the papers co-authored by Dr. Carlos Chacón-Martínez embrace a 2021 one on hair follicle stem cell fate.

Electrical Stimulation of the Scalp

Interestingly, certainly one of his patents pertains to an electrical machine to stimulate hair progress. It was filed in 2020 by Mane Biotech and continues to be pending. I believe that niostem’s new low-level electrical stimulation hair progress machine makes use of the discoveries within the above patent.

Although this idea may sound like fantasy, I really wrote a complete publish on electrical energy and hair progress up to now. There is a few proof that electrical stimulation can reactivate the dormant stem cells surrounding miniaturized hair follicles. Thereby resulting in hair regeneration.

On a associated notice, hair progress lasers additionally work by way of an identical idea, however contain gentle vitality as an alternative of electrical energy. And lately, I additionally mentioned sound vitality and hair progress.

Niostem Device Releasing in 2023

Niostem Wearable Device
Niostem Wearable Device.

According to the podcast embedded on the backside of this publish, the wearable machine is light-weight and wi-fi. It must be used a number of days every week for all times if you wish to maintain on to any good points. On niostem’s web site FAQ part, it says the product will launch in 2023.

Among some great benefits of this machine versus most present hair loss remedy choices embrace:

  • No negative effects that may occur with medicines.
  • Ease of use. You can put on it like a cap or helmet whereas doing chores. But don’t use it outdoor in case of rain or snow.
  • No messy software course of resembling with topical hair loss merchandise or hair thinning shampoos.

Niostem’s Twitter and Instagram pages could be adopted for the most recent updates.

Last month, Dr. Chacon gave an interview on the “Products with Purpose” podcast that’s price a hear. The firm has been engaged on this wearable machine for nearly 4 years. He mentions that they verified their outcomes at the well-known third celebration Monasterium Laboratory. The hair progress enhance after 6 months of machine use was 19%.

They plan to launch an Indiegogo crowdfunding spherical in March. This know-how has additional implications to general stem cell rejuvenation and human well being and longevity.

[ad_2]

Source by [author_name]

Leave a comment

Your email address will not be published. Required fields are marked *